v3.26.1
Investment in MiNK Therapeutics, Inc. (Tables)
3 Months Ended
Mar. 31, 2026
Investment Company [Abstract]  
Summarized Balance Sheet Information and Results of Operations The following tables present summarized balance sheet information as of March 31, 2026 and summarized results of operations for the three months ended March 31, 2026 (in thousands):

 

 

 

March 31, 2026

 

Current assets

 

$

10,022

 

Non-current assets

 

 

355

 

Current liabilities

 

 

7,287

 

Non-current liabilities

 

 

15,776

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

 

2026

 

Net loss

 

$

(2,742

)

Net loss attributable to Agenus

 

 

(1,206

)